Searchable abstracts of presentations at key conferences in endocrinology

ea0063p1098 | Pituitary and Neuroendocrinology 3 | ECE2019

The long time observation, treatment modalities and outcomes in patients with childhood/adult onset of craniopharyngioma

Gilis-Januszewska Aleksandra , Kluczyński Łukasz , Rogoziński Damian , Pantofliński Jacek , Zygmunt-Gorska Agata , Wojcik Małgorzata , Starzyk Jerzy , Hubalewska-Dydejczyk Alicja

Background: Craniopharyngiomas are rare, relatively benign, slowly growing intracranial tumors originating in pituitary gland embryonic tissue. They may present at any age, with two peaks of occurrence in children and in older adults. Clinical symptoms are the result of mass effects. Treatment options include surgery, radio- and chemotherapy and unfortunately are connected with a high ratio of postoperative pituitary insufficiency.Aim: To present the lon...

ea0049ep283 | Calcium & Vitamin D metabolism | ECE2017

When is it worthwhile to perform parathyroid SPECT/CT scintigraphy in primary hyperparathyroidism?

Trofimiuk-Muldner Malgorzata , Skalniak Anna , Kulczynski Lukasz , Zapendowska-Dudek Aleksandra , Budek Aneta , Buziak-Bereza Monika , Sowa-Staszczak Anna , Hubalewska-Dydejczyk Alicja

Introduction: Observed increasing frequencies of asymptomatic or oligosymptomatic PHP cases may increase the rate of false negative imaging results.Aim: To determine the level of PTH and calcium at which an enlarged parathyroid gland can be detected by parathyroid SPECT/CT.Material and methods: A retrospective analysis of 117 patients diagnosed with PHP (100 females and 17 males, aged 16–88 years) was performed. In each patien...

ea0037gp.26.10 | Thyroid – hypothyroidism | ECE2015

HLA-DR in Hashimoto's thyroiditis

Jabrocka-Hybel Agata , Skalniak Anna , Pietkowski Jakub , Turek-Jabrocka Renata , Vyhouskaya Palina , Tsang Adrian , Lizis-Kolus Katarzyna , Sokolowski Grzegorz , Pach Dorota , Hubalewska-Dydejczyk Alicja

Background: The human leukocyte antigen (HLA) cluster is a genetic region that has been associated with multiple autoimmune disorders, also with autoimmune thyroid diseases. Plenty attempts to establish the significance of class II HLA-DR in Hashimoto’s thyroiditis (HT) development were undertaken in the past; however, reports are rather divergent. This might be caused by different criteria used to diagnose HT. There is however an alternative hypothesis, according to whic...

ea0022p856 | Thyroid | ECE2010

The limitations of thyroid volume reference values in assessment of iodine nutrition after recent introduction of iodine prophylaxis

Trofimiuk Malgorzata , Buziak-Bereza Monika , Szybinski Zbigniew , Lewinski Andrzej , Zygmunt Arkadiusz , Golkowski Filip , Sowinski Jerzy , Dorant Bohdana , Bandurska-Stankiewicz Elzbieta , Naskalski Jerzy , Rostworowski Witold , Hubalewska-Dydejczyk Alicja

Goiter frequency (GF) in schoolchildren and urinary iodine concentration (UIC) in an appropriately large population sample are iodine nutrition (IN) best indicators. GF in mildly iodine deficient areas should be assessed ultrasonographically, as palpation sensitivity in such cases is low.Aim: To assess thyroid volume reference values as IN marker in population with recently introduced obligatory iodine prophylaxis (OIP).Material an...

ea0020p203 | Endocrine tumours and neoplasia | ECE2009

Efficacy and safety of 90Y-DOTATATE therapy in neuroendocrine tumours (NETs)

Sowa-Staszczak Anna , Hubalewska-Dydejczyk Alicja , Kunikowska Jolanta , Krolicki Leszek , Mikolajczak Renata , Pawlak Dariusz , Gilis-Januszewska Aleksandra , Trofimiuk Malgorzata , Stefanska Agnieszka

Therapy with labeled somatostatin analogues is the modern approach to patients with disseminated or unresectable NETs expressing somatostatin receptors (SSTR). Octreotate is the somatostatin analogue with high affinity to SSTR type 2, most commonly present in NETs. The aim of the study was to assess the efficacy and toxicity of peptide receptor radionuclide therapy (PRRT) with the use of 90Y labelled Tyr3-octreotate, (90Y-DOTATATE) in NETs....

ea0020p214 | Endocrine tumours and neoplasia | ECE2009

The retrospective analysis of the pheochromocytoma diagnostic procedures in patients after laparoscopic adrenalectomy

Hubalewska-Dydejczyk Alicja , Budzynski Andrzej , Buziak-Bereza Monika , Pach Dorota , Stochmal Ewa , Trofimiuk Malgorzata , Przybylik-Mazurek Elwira , Chrzan Robert , Karcz Danuta , Urbanik Andrzej

The pheochromocytoma (PH) diagnosis is often very difficult, particularly in asymptomatic or oligosymptomatic patients. Every subject with adrenal tumor should be screened for PH, although many factors may interfere with biochemical evaluation. The false positive testing for PH may result in unnecessary surgical treatment.Methods: Retrospective analysis of 45 patients after laparoscopic adrenalectomy due to suspicion of PH (based on biochemical testing) ...

ea0020p299 | Clinical case reports and clinical reports | ECE2009

Nuroendocrine tumours of unusual localization

Trofimiuk Malgorzata , Hubalewska-Dydejczyk Alicja , Pach Dorota , Sowa-Staszczak Anna , Szybinski Piotr , Kulig Jan , Anielski Ryszard , Cichon Stanislaw , Matlok Maciej , Karcz Danuta , Bonicki Wieslaw

Neuroendocrine tumours (NETs) are rare neoplasm arising from dispersed endocrine system. Their incidence is estimated to be five cases per 100 000 population, although the true incidence may be higher as the consequence of often oligosymptomatic course of disease and indolent behaviour of NETs. The most typical localization of NETs is gastrointestinal tract and bronchi. However they may develop in every organ of the body containing neuroendocrine cells. The diagnosis of NET is...

ea0020p339 | Diabetes and Cardiovascular | ECE2009

Change of physical activity, diet habits and risk of diabetes after lifestyle intervention. Diabetes in Europe: prevention using lifestyle, physical activity, and nutritional intervention: the DePlan Project Krakow

Gilis-Januszewska Aleksandra , Hubalewska-Dydejczyk Alicja , Piwonska-Solska Beata , Szybinski Zbigniew , Linstrom Jaana , Peltonen Marku , Schwarz Peter , Barengo Noel , Tuomilehto Jaakko

Aim: Aim of the study was to assess the effectiveness of the structured lifestyle intervention in diabetes type 2 high risk people.Methods: The De-Plan Project participants were selected based on FINDRISK over 14. Exclusion criteria were known or OGTT diabetes. Intervention completed by 175 participants consisted of 10 group sessions on lifestyle changes, diet and physical activity education, and 6 telephone motivation sessions and voluntary physical act...

ea0016p294 | Endocrine tumours | ECE2008

Expression of the somatostatin receptors (SSTRs) in patients with gastro-pancreatic neuroendocrine tumours (GEP-NET) and medullary thyroid cancers (MTC)

Hubalewska-Dydejczyk Alicja , Szybinski Piotr , Trofimiuk Malgorzata , Stachura Jerzy , Wierzchowski Wojciech , Sowa-Staszczak Anna , Pach Dorota , Fross-Baron Katarzyna , Kulig Jan , Huszno Bohdan

The pattern of SSTRs expression in neuroendocrine neoplasms determines the possibility of the detection of the primary tumour and distant metastases, the application of radio-guided surgery (RGS) and the outcome of the treatment with itrium or lutetium labeled somatostatin analogues. The frequency and expression pattern of each subtype of SSTRs not only vary considerably in different NET but also in each patient.The aim of the study was to assess the SST...

ea0014p131 | (1) | ECE2007

Results 90Y-DOTATATE therapy in patients with neuroendocrine tumours (NETs) - own experience

Kunikowska Jolanta , Hubalewska-Dydejczyk Alicja , Sowa-Staszczak Anna , Krolicki Leszek , Ochman Pawel , Mikolajczak Renata , Pawlak Dariusz , Kobylecka Malgorzata , Maczewska Joanna , Huszno Bohdan

In the 1980 s the discovery of expression of somatostatin receptors on NET cells made the use of somatostatin analogues in diagnosis and therapy possible.The aim: Of the study was to assess response of targeted radio-nuclide therapy with radio-labelled somatostatin analogue 90Y-[DOTA0,D-Phe1,Tyr3]-octreotate (DOTATATE) in treatment of disseminated NETs.Material and methods: 12 patients (a...